Search results
13 hours ago · Market Driver. The peripheral neuropathy treatment market is poised for growth due to the strong pipeline of drugs from key vendors. These drugs, currently undergoing clinical trials, include WinSanTor, Inc.’s WST-057 (completed Phase I), Astellas Pharma’s ASP3662 (Phase II), AstraZeneca Plc’s MEDI7352 (Phase I), Diabetic nephropathy’s unnamed molecule (Phase III), and Octapharma AG ...
